Abstract
In order to develop promising cyclin dependent kinase 1 inhibitors, homology modeling, docking and molecular dynamic simulation techniques were applied to get insight into the functional and structural properties of cyclin dependent kinase 1 (CDK1). Since there is no reported CDK1 crystal structural data, the three dimensional structure of CDK1 was constructed based on homology modeling. An extensive dynamic simulation was also performed on a Flavopiridol-CDK1 complex for probing the binding pattern of Flavopiridol in the active site of CDK1. The binding modes of other inhibitors to CDK1 were also proposed by molecular docking. The structural requirement for developing more potent CDK1 inhibitors was obtained by the above-mentioned molecular simulations and pharmacophore modeling.
Similar content being viewed by others
References
Lees E (1995) Curr Opin Cell Biol 7:773–780
Morgan DO (1997) Annu Rev Cell Dev Bi 13:261–291
Jeffrey PD, Russo AA, Polyak K, Gibbs E, Hurwitz J, Massague J, Pavletich NP (1995) Nature 376:313–320
Dunphy WG (1994) Trends Cell Biol 4:202–207
Hoffman I, Karsenti E (1994) J Cell Sci 18:75–79
Hochegger H, Takeda S, Hunt T (2008) Nat Rev Mol Cell Bio 9:910–U926
Knockaert M, Greengard P, Meijer L (2002) Trends Pharmacol Sci 23:417–425
Villerbu N, Gaben AM, Redeuilh G, Mester J (2002) Int J Cancer 97:761–769
Havlicek L, Hanus J, Vesely J, Leclerc S, Meijer L, Shaw G, Strnad M (1997) J Med Chem 40:408–412
Moon MJ, Lee SK, Lee JW, Song WK, Kim SW, Kim JI, Cho C, Choi SJ, Kim YC (2006) Bioorg Med Chem 14:237–246
Joshi KS, Rathos MJ, Joshi RD, Sivakumar M, Mascarenhas M, Kamble S, Lal B, Sharma S (2007) Mol Cancer Ther 6:918–925
DePinto W, Chu XJ, Yin XF, Smith M, Packman K, Goelzer P, Lovey A, Chen YS, Qian H, Hamid R, Xiang Q, Tovar C, Blain R, Nevins T, Higgins B, Luistro L, Kolinsky K, Felix B, Hussain S, Heimbrook D (2006) Mol Cancer Ther 5:2644–2658
Byth KF, Geh C, Forder CL, Oakes SE, Thomas AP (2006) Mol Cancer Ther 5:655–664
Aoyagi Y, Masuko N, Ohkubo S, Kitade M, Nagai K, Okazaki S, Wierzba K, Terada T, Sugimoto Y, Yamada Y (2005) Cancer Sci 96:614–619
Brana MF, Cacho M, Garcia ML, Mayoral EP, Lopez B, de Pascual-Teresa B, Ramos A, Acero N, Llinares F, Munoz-Mingarro D, Lozach O, Meijer L (2005) J Med Chem 48:6843–6854
Sielecki TM, Boylan JF, Benfield PA, Trainor GL (2000) J Med Chem 43:1–18
Dasmahapatra GP, Didolkar P, Alley MC, Ghosh S, Sausville EA, Roy KK (2004) Clin Cancer Res 10:5242–5252
Grosios K (2001) Curr Opin Invest Drugs 2:287–297
Schmid WF, John RO, Muhlgassner G, Heffeter P, Jakupec MA, Galanski M, Berger W, Arion VB, Keppler BK (2007) J Med Chem 50:6343–6355
Li YL, Fang H, Xu WF, Wang BH (2008) Chin Chem Lett 19:541–543
Shi JY, Blundell TL, Mizuguchi K (2001) J Mol Biol 310:243–257
Blundell TL, Elliott G, Gardner SP, Hubbard T, Islam S, Johnson M, Mantafounis D, Murray-Rust P, Overington J, Pitts JE, Sali A, Sibanda BL, Singh J, Sternberg MJE, Sutcliffe MJ, Thornton JM, Travers P (1989) Phil Trans R Soc Lond B 324:447–460
Lüthy R, McLachlan AD, David E (1991) Proteins 10:229–239
Lüthy R, Bowie JU, Eisenberg D (1992) Nature 356:83–85
Berendsen HJC, van der Spoel D, van Drunen R (1995) Comput Phys Commun Package 91:43–56
Lindahl E, Hess B, van der Spoel D (2001) J Mol Model 7:306–317
Van der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJC (2005) J Comput Chem 26:1701–1718
Brusselbach S, Nettelbeck DM, Sedlacek HH, Muller R (1998) Int J Cancer 77:146–152
Rarey M, Kramer B, Lengauer T, Klebe G (1996) J Mol Biol 261:470–489
Rarey M, Kramer B, Lengauer T (1997) J Comput Aided Mol Des 11:369–384
Darden T, York D, Pedersen L (1993) J Chem Phys 98:10089–10092
McClue SJ, Blake D, Clarke R, Cowan A, Cummings L, Fischer PM, MacKenzie M, Melville J, Stewart K, Wang SD, Zhelev N, Zheleva D, Lane DP (2002) Int J Cancer 102:463–468
Gherardi D, D’Agati V, Chu THT, Barnett A, Gianella-Borradori A, Gelman IH, Nelson PJ (2004) J Am Soc Nephrol 15:1212–1222
Kim KS, Sack JS, Tokarski JS, Qian LG, Chao ST, Leith L, Kelly YF, Misra RN, Hunt JT, Kimball SD, Humphreys WG, Wautlet BS, Mulheron JG, Webster KR (2000) J Med Chem 43:4126–4134
Clement OA, Mehl AT (2000) HipHop: pharmacophores based on multiple common-feature alignments. In: Güner OF (ed) Pharmacophore Perception. Development & Use In Drug Design. International University Line, La Jolla, pp 69–84
Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) J Comput Chem 25:1605–1612
Acknowledgments
This work was supported by Project of Science and Technology Research in Shandong Province (2008GG10002010) and Independent Innovation Foundation of Shandong University, IIFSDU (2009TS111). We also acknowledge Accelrys Inc. for providing the Discovery Studio 2.5 package.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Zhang, L., Zhu, H., Wang, Q. et al. Homology modeling, molecular dynamic simulation and docking studies of cyclin dependent kinase 1. J Mol Model 17, 219–226 (2011). https://doi.org/10.1007/s00894-010-0710-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00894-010-0710-z